Literature DB >> 7890306

Expression of TGF-beta in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFN-gamma, but enhancement of IL-10, in carrageenin-induced oedema in mice.

A Ianaro1, D Xu, C A O'Donnell, M Di Rosa, F Y Liew.   

Abstract

Mice injected with carrageenin in the footpad developed local inflammation which peaked at 48 hr. This was significantly reduced in mice inoculated orally with an attenuated Salmonella construct expressing transforming growth factor-beta (TGF-beta). Administration of the Salmonella construct alone had no effect on inflammation. High levels of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) were secreted by draining lymph node cells from mice injected with carrageenin following stimulation in vitro. Prior inoculation with Salmonella enhanced the production of IL-2 and IFN-gamma from the draining lymph node cells. Administration of the Salmonella-TGF-beta construct significantly inhibited the production of these cytokines. In contrast, IL-10 only was secreted from draining lymph node cells of animals inoculated with the Salmonella-TGF-beta construct. Thus, oral administration of TGF-beta can significantly inhibit local inflammation and alter the cytokine secretion pattern of cells from lymph nodes draining the site of inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890306      PMCID: PMC1415173     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

1.  Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis.

Authors:  A Barral; M Barral-Netto; E C Yong; C E Brownell; D R Twardzik; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

2.  Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

Authors:  C W Czarniecki; H H Chiu; G H Wong; S M McCabe; M A Palladino
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

3.  Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis.

Authors:  R Strugnell; G Dougan; S Chatfield; I Charles; N Fairweather; J Tite; J L Li; J Beesley; M Roberts
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

4.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

5.  A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice.

Authors:  A Ianaro; C A O'Donnell; M Di Rosa; F Y Liew
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

6.  Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.

Authors:  A H Rook; J H Kehrl; L M Wakefield; A B Roberts; M B Sporn; D B Burlington; H C Lane; A S Fauci
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

7.  Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta.

Authors:  S M Wahl; J B Allen; G L Costa; H L Wong; J R Dasch
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

8.  Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells.

Authors:  R K Assoian; M B Sporn
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

9.  Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

Authors:  J H Kehrl; L M Wakefield; A B Roberts; S Jakowlew; M Alvarez-Mon; R Derynck; M B Sporn; A S Fauci
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

10.  Interferon gamma inhibits interleukin 10 production by monocytes.

Authors:  P Chomarat; M C Rissoan; J Banchereau; P Miossec
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  5 in total

1.  Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect.

Authors:  Asif J Iqbal; André L F Sampaio; Francesco Maione; Karin V Greco; Toshiro Niki; Mitsuomi Hirashima; Mauro Perretti; Dianne Cooper
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

2.  Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice.

Authors:  Hong Hua Piao; Vo Thi Minh Tam; Hee Sam Na; Hyun Ju Kim; Phil Youl Ryu; Soo Young Kim; Joon Haeng Rhee; Hyon E Choy; Suhng Wook Kim; Yeongjin Hong
Journal:  J Microbiol       Date:  2010-08-20       Impact factor: 3.422

3.  Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice.

Authors:  K L Karem; S Chatfield; N Kuklin; B T Rouse
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

4.  Carrageenan reduces bone morphogenetic protein-4 (BMP4) and activates the Wnt/beta-catenin pathway in normal human colonocytes.

Authors:  Sumit Bhattacharyya; Alip Borthakur; Pradeep K Dudeja; Joanne K Tobacman
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

5.  Perthamide C inhibits eNOS and iNOS expression and has immunomodulating activity in vivo.

Authors:  Mariarosaria Bucci; Anna Cantalupo; Valentina Vellecco; Elisabetta Panza; Maria Chiara Monti; Angela Zampella; Angela Ianaro; Giuseppe Cirino
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.